TL;DR
Get self-care and calm essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A study in Nature Communications links the gut-bacteria-produced molecule imidazole propionate, or ImP, with Alzheimer’s-related biological markers and faster cognitive decline. Mouse experiments and human blood-sample findings point to a possible pathway, but the study does not establish that ImP causes Alzheimer’s or show that lowering it prevents the disease.
Researchers report that imidazole propionate (ImP), a molecule made by some gut bacteria, may be connected to Alzheimer’s-related brain changes: in mice it increased abnormal amyloid and tau accumulation, while in a study of nearly 1,200 people, higher blood levels were associated with disease-related markers and faster cognitive decline. The findings identify a possible research target, but do not show that ImP causes Alzheimer’s in people or that reducing it prevents dementia.
The study, published in Nature Communications, was led by researchers at the University of Wisconsin-Madison, including medicine professor Barbara Bendlin and bacteriology professor Federico Rey. The team examined ImP, a compound produced by certain intestinal bacteria as they use histidine, an amino acid found in many foods. ImP production differs among people, and the researchers say bacteria that make it can be present without being abundant.
In experiments with mice, ImP that reached the brain was linked to increased accumulation of abnormal beta-amyloid and tau proteins, which are associated with Alzheimer’s disease. The researchers also analyzed blood samples from nearly 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies associated with the Wisconsin Alzheimer’s Disease Research Center. Participants with higher ImP concentrations were more likely to have biological markers related to abnormal proteins and impaired neuron function.
Because participants had taken cognitive tests over time, the team compared blood ImP levels with changes in thinking and memory. Higher levels were associated with faster cognitive decline. The study also found a genetic variation associated with substantially higher ImP in blood; about 43% of participants carried it. The researchers suspect the variation may affect how efficiently the kidneys clear ImP, but that explanation remains a hypothesis.
A Possible Target Beyond Diet
The results may help explain one route by which gut activity and the brain could be connected in dementia. The researchers say ImP could be a potential target for future prevention or treatment research, particularly if scientists can find a way to lower circulating levels without disrupting essential nutrition.
The findings do not establish that ImP is a cause of Alzheimer’s, and they do not show that changing gut bacteria or reducing ImP would alter a person’s risk. Still, identifying a specific molecule and a genetic variation associated with its blood levels gives researchers a defined mechanism to test. Any eventual treatment would require further study to determine whether lowering ImP is safe and improves meaningful outcomes.
probiotic supplements for gut health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Gut Differences to ImP
The work follows earlier research by Bendlin and Rey’s team, which found differences in the intestinal microorganisms of people with Alzheimer’s disease compared with healthy individuals. The researchers have since investigated whether those differences might relate to changes in the brain. The new study focuses on ImP as one possible link, rather than suggesting that gut microbes as a whole explain Alzheimer’s.
Previous research has linked ImP to type 2 diabetes and coronary artery disease, according to the study report. The compound can enter the bloodstream after it is produced in the gut, providing a possible route to organs beyond the digestive system. The current findings extend that line of investigation to brain-related markers and cognitive change.
The researchers caution that diet is not a simple way to target ImP. Because gut bacteria produce it while using histidine, and histidine is an essential amino acid found across many foods, the team says eliminating particular foods is not a straightforward solution. Bendlin said, “Generally improving your diet would probably help,” while also warning against reducing the finding to avoiding eggs or red meat.
“A microbe doesn’t have to be abundant to have an impact on the host.”
— Federico Rey, University of Wisconsin-Madison professor of bacteriology
dietary supplements to support brain health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Cause, Clearance and Treatment
The human results show associations, not proof of cause. The study does not establish whether higher ImP contributes to cognitive decline, whether developing disease affects ImP levels, or whether another factor influences both. The mouse experiments offer evidence of a possible biological effect, but do not establish that the same process drives disease in people.
It is also unclear how the genetic variation raises blood ImP. The researchers suspect it may affect kidney clearance, but the source report describes this as a possibility rather than a confirmed mechanism. The study does not provide evidence that an ImP-lowering drug is available, or that dietary changes can reliably lower levels or reduce Alzheimer’s risk.
blood test kits for cognitive decline markers
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing ImP-Lowering Approaches
The next research question is whether lowering ImP can change Alzheimer’s-related outcomes, rather than only being associated with them. The team has proposed investigating inhibitors that reduce ImP in the bloodstream. Any such approach would need to be developed and tested before researchers could determine its safety or benefit.
Further work will also be needed to clarify how ImP is produced, how it moves through the body, and whether the genetic variation affects kidney removal as suspected. The report does not give a timeline for clinical trials or say that a treatment is imminent. For now, the findings add a candidate molecule to ongoing research into the relationship between gut microbes and dementia.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is ImP?
Imidazole propionate (ImP) is a molecule produced by certain gut bacteria as they use histidine, an amino acid essential to human health.
Does this study prove ImP causes Alzheimer’s disease?
No. The study reports mouse findings and associations between blood ImP, disease-related biological markers and cognitive decline in people. Those findings do not prove that ImP causes Alzheimer’s in humans.
Should people avoid particular foods to lower ImP?
The researchers did not recommend avoiding specific foods. Histidine is essential and widely present in foods, and the report says diet alone may not be a straightforward way to lower ImP.
Is there an ImP-lowering treatment available?
The report describes a possible future treatment target, not an available therapy. Researchers say they hope to investigate inhibitors that might lower ImP in the blood; their safety and effectiveness have not been established.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
